Gemma Jones

Reporter for @PMLIVEcom and PME magazine, covering #pharma #biotech #hcsmeu #hcmktg #heor #medcomms

[Gemma Jones @PME_pharma]

In this month's PME, I interview @90TEN's senior account director @jensquibbs on the best and worst things about working in healthcare comms, why we sleep, and seafood tapas. Alternatively, read it on @PMLiVEcom here: https://t.co/cNhHKA3RAg

#medcomms #healthcare

[Gemma Jones @PME_pharma]

Love Island ads fuel body image problems, warn health leaders. Read more here: https://t.co/Tvz1fmMNgE #loveisland #bodyimage #mentalhealth #healthcare #NHS

[Gemma Jones @PME_pharma]

Axovant licenses another gene therapy as new strategy beds in https://t.co/Ao8RwiKIGY #Pharma #GeneTherapy

[Debbie Tuesley @Debst11]

PMEA 2018 gives you and your team the opportunity to highlight the projects and campaigns you/your clients deliver which improve patient care and outcomes and provide greater value for healthcare providers and payers. Enter at https://t.co/k2dElEHxZd

[Gemma Jones @PME_pharma]

The evolution of the #pharmaceutical industry over the last 40 years has been punctuated by periods of erosion of its influence, usually catalysed by new regulations or new stakeholders with novel #technology or business models. Read more here: https://t.co/tH0PFNpnGw #data

[Gemma Jones @PME_pharma]

Trial data suggest Abivax’ drug may clear latent HIV https://t.co/3y5L5JUxmq #Pharma #HIV

[Pharmaceutical Market Europe @PMLiVEcom]

Recognising excellence in improving patient outcomes, PMEA gives you and your teams the opportunity to celebrate the excellent work you are carrying out. Download the entry kit here: https://t.co/oOIR7FO2r1 or for more details click the following link: https://t.co/cpxEjFKR5z

[Gemma Jones @PME_pharma]

A year ago, regulators slapped warnings to the labelling for Johnson & Johnson’s diabetes drug Invokana, setting it at a disadvantage against rival drugs in the SGLT2 inhibitor class, but now the company is fighting back. Read more here: https://t.co/Egt6H69mv0 #Pharma

[Gemma Jones @PME_pharma]

Incyte is still trying to recover from the mauling it took after its IDO inhibitor epacadostat for cancer failed earlier this year, and yesterday wrote off another programme in non-Hodgkin’s lymphoma. Read more here: https://t.co/Q1lu5qLfUs #Pharma

[Gemma Jones @PME_pharma]

Roche is reshuffling its executive team, again https://t.co/tOX1lDKsdN #Pharma

[Gemma Jones @PME_pharma]

Heron Pharma has new data on its combination anaesthetic drug, and a breakthrough designation from the FDA, which suggests it could have an impact on the post-operative pain market. Read more here: https://t.co/reS2NraCzx #Pharma

[Gemma Jones @PME_pharma]

Alexion is pulling out all the stops to get speedy approval for a follow-up to its rare blood disorder therapy Soliris, using a coveted priority review voucher (PRV) to accelerate the FDA’s review. Read more here: https://t.co/hqGujHofZd #Pharma

[Gemma Jones @PME_pharma]

Amazon, JPMorgan and Warren Buffet’s Berkshire Hathaway have a high-profile chief executive for its non-profit healthcare company, recruiting Brigham and Women’s Hospital surgeon Dr Atul Gawande. Read more here: https://t.co/BVAnUbmfXE #Amazon #healthcare

[Gemma Jones @PME_pharma]

The shortlist for one of the UK’s most prestigious pharma industry prizes has been announced, and illustrates the growing number of orphan drugs reaching the market. Read more here: https://t.co/8pIspr4wWt #Pharma

[Debbie Tuesley @Debst11]

PMEA 2018 has launched! Give your work the recognition it deserves. Download the entry kit https://t.co/2KnAAo3Yhr and find out more https://t.co/jnhpTEaf2O #pmea2018 #awards #success #patientoutcomes

[Gemma Jones @PME_pharma]

A survey by the Irish government of companies’ concerns about Brexit has found that access to skilled workers is top of the list for the pharmaceutical and chemical sectors. Read more here: https://t.co/f8hwyLJGx8 #Pharma

[Gemma Jones @PME_pharma]

Find out why analysts are calling @Sarepta a leader in the DMD field: https://t.co/Dtm4vN85c1 #Pharma #Healthcare

[Gemma Jones @PME_pharma]

Sanofi has appointed car maker Peugeot's finance director Jean-Baptiste Chasseloup de Chatillon to take over as its new chief financial officer. Read more here: https://t.co/EaWcGYuYAK #Pharma

[Gemma Jones @PME_pharma]

UK start-up Freeline Therapeutics has raised an impressive £88m ($116m) in a second-round financing that will allow it to fund additional testing of its lead haemophilia B #GeneTherapy , and take another for Fabry disease into the clinic. Read more here: https://t.co/ShlykQV2Ig

[Gemma Jones @PME_pharma]

Three years after taking a $1bn stake in Foundation Medicine, Roche has decided it wants to take complete control of the genomics specialist, which focuses on personalised cancer therapies. Read more here: https://t.co/hAjBsoY2k0 #Pharma